Taipei Medical University and MSD Launch Collaboration to Enhance Healthcare Innovation in Taiwan

Taipei, Taiwan – April 7, 2025 – Taipei Medical University (TMU) and Merck Sharp & Dohme (MSD) Taiwan have signed a memorandum of understanding to collaborate in six key directions aiming to advance healthcare in Taiwan. This partnership—the very first large-scale alliance between a global pharmaceutical company and a medical university in Taiwan—will inject international resources into the country's healthcare innovation ecosystem and enhance its biotechnology and pharmaceutical competitiveness.